Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant Patients
- Conditions
- Hematologic Malignancies
- Registration Number
- NCT03212560
- Lead Sponsor
- Gazi University
- Brief Summary
Hematologic malignancies are neoplasms that affect the blood, bone marrow, and lymph nodes. Hematological malignancies are the most common forms of leukemia, lymphoma, and myeloma, with numerous subtypes. The general symptoms of leukemia are fatigue, increased susceptibility to infection, bleeding, and the formation of bruises easily. Typical lymphoma symptoms are night sweats and involuntary weight loss, recurrent fever, fatigue, and itching. Myeloma patients often have bone pain, fatigue, anemia, hypercalcemia or infection symptoms.
Adverse effects of hematologic malignancies and treatments cause abnormality in physical function and quality of life. Treatments such as chemotherapy, radiotherapy and hematopoietic stem cell transplantation, which may have side effects on the body systems are used in early or late period. The most common side effect due to chemotherapy is fatigue. Vomiting, weight loss, anemia, depression, decreased aerobic capacity, loss of muscle strength, decreased physical functioning and deterioration in the quality of life are indirect side effects seen in patients.
In the literature, side effects of hematological malignancies have been investigated after treatment in patients. However, no study investigated exercise capacity, quality of life, physical activity level and pulmonary functions on newly diagnosed hematologic malignant patients. Therefore, the investigators aimed to compare aforementioned outcomes in newly diagnosed hematologic malignant patients and healthy controls.
- Detailed Description
According to sample size calculation 30 newly diagnosed hematologic malignant patients and 30 healthy individuals will be included. Before treatment submaximal exercise capacity, physical activity, quality of life, pulmonary functions, respiratory and peripheral muscle strength, respiratory muscle endurance, dyspnea and fatigue perception, anxiety and depression will be evaluated. Primary outcome measurements are exercise capacity, physical activity, quality of life, secondary outcomes are respiratory and peripheral muscle strength, respiratory muscle endurance, pulmonary functions, dyspnea and fatigue perception, anxiety and depression.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Newly diagnosed hematological malignant patients
- 18-65 years of age
- under standard medications.
- having cognitive disorder,
- orthopedic or neurological disease with a potential to affect functional capacity,
- comorbidities such as asthma, chronic obstructive pulmonary disease (COPD), acute infections or pneumonia,
- problems which may prevent evaluating such as visual problems and mucositis
- having metastasis to any region (bone etc.)
- having acute hemorrhage in the intracranial and / or lung and other areas
- having any contraindication to exercise training
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease-specific quality of life second day The Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu)
Functional exercise capacity first day Evaluated using 6-minute walking test
FACT second day The Functional Assessment of Cancer Therapy-Anemia (FACT-An)
Physical activity first day Evaluated using a metabolic holter
General quality of life second day Evaluated using QOL using European Organization for Research and Treatment of Cancer QOL Questionnaire (EORTCQOL)
- Secondary Outcome Measures
Name Time Method Pulmonary functions first day Evaluated using spirometer
Hospital depression second day Evaluated using Hospital Anxiety and Depression Scale
Anxiety second day Evaluated using Hospital Anxiety and Depression Scale
Respiratory muscle strength second day Evaluated using mouth pressure device
Fatigue second day Evaluated using Fatigue Severity Scale
Dyspnea first day Evaluated using Modified Medical Research Council Dyspnea scale (MMRC)
Activity dyspnea first day Evaluated using Modified Borg Scale
Depression second day Montgomery-Åsberg Depression Rating Scale
Muscle strength second day Evaluated using hand-held dynamometer for peripheral muscles (shoulder abduction, shoulder flexion, knee extension, hand grip strength)
Respiratory muscle endurance second day Evaluated using respiratory muscle trainer (POWERbreathe)
Trial Locations
- Locations (1)
Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation
🇹🇷Yenimahalle, Turkey